FindTrial
Sign In

The role of the phosphorylation of CFL1 and PHB in the mechanism of ovrian cancer drug-resistance

The role of the phosphorylation of CFL1 and PHB in the mechanism taxol-resistance of ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021718
Enrollment
Unknown
Registered
2019-03-06
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

chemo-sensitive group:no invention
chemo-resistant group:no intervention

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: primary ovarian malignances

Exclusion criteria

Exclusion criteria: metastatic ovarian malignanceshistory of mental disorders and without ability to sign informed consent

Design outcomes

Primary

MeasureTime frame
progression-free survival ;—

Secondary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactLi Min

Department of Gynecology and Obstetrics, Beijing Hospital

mindy99999@126.com+86 13811526308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026